GENDER AND AGE DISTRIBUTION, AND URINARY METABOLIC ABNORMALITIES IN PATIENTS WITH RECURRENT URINARY TRACT STONES

Muhammad Naeem, Tariq Ahmad, Muhammad Kamran Khan, Hazrat Ullah

Abstract


Background: Urolithiasis is one of the most common urological disorders. Patients with recurrent urinary tract stones may have underlying metabolic abnormality. The objectives of this study were to determine the gender and age distribution, and frequency of common urinary metabolic abnormalities in patients with recurrent urinary tract stones.
Material & Methods: This cross-sectional study was conducted in Department of Urology, Institute of Kidney Diseases, Peshawar from August 2011 to June 2012. Patients above 13 years presenting with recurrent urinary tract stones were included. 24-hour urine sample was sent for metabolic abnormalities. Gender, age in years, and age grouping were demographic while presence of hypercalciuria, hyperoxaluria, hyperuricosuria and hy¬pocitraturia were research variables.
Results: Out of 70 patients, males were 45 (64.3%) and females were 25 (35.7%). Mean age was 29.72± 8.5 (16-68) years. Hypercalciuria was noted in 34 (48.60%) patients with 20 (28.6%) males and 14 (20.0%) females. The highest number of patients i.e 21(30.0%) was noted in age group 21-30 years. Hyperuricosuria was noted in 12 (17.19%) patients. The highest number of patients i.e. nine (12.9%) was noted in age group 21-30 years. Hyperoxaluria was reported in 16 (22.90%) patients. The highest number of patients i.e. nine (12.9%) was noted in age group 21-30 years. Hypocitraturia was noted in 22 (31.44%) patients. The highest number i.e. 14 (20.0%) with hypocitraturia was noted in age group 21-30 years.
Conclusion: Recurrent stone former have high frequency of metabolic abnormalities. Prompt treatment of these abnormalities will decrease the chances of recurrent stone formation.

Keywords


Urolithiasis, Urinary Tract Stones, Renal Colic; Hematuria; Renal Failure; Urinalysis; Hypercalciuria; Hyperoxaluria; Hyperuricosuria; Hypocitraturia.

Full Text:

PDF

References


Fwu CW, Eggers PW, Kimmel PL, Kusek JW, Kirkali Z. Emergency department visits, use of imaging and drugs for urolithiasis have increased in the United States. Kidney Int 2013; 83(3): 479-86.

Stechman MJ, Loh NY, Thakker RV. Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol 2009;24:2321-32.

Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol 2005;173:848-57.

Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int 2009; 75(6):585-95.

Chandhoke S. Evaluation of recurrent stone former. Urol clin N Am 34;2007:315-22.

Fink HA, Akornor JW, Garimella PS, MacDonald, Cutting A, Rutks IR, et al. Diet, fluid, or supplement for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 2009;56:72-80.

Castle SM, Cooperberg MR, Sadetsky N, Eisner BH, Stoller ML. Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis. J Urol 2010;184:579-83.

Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. J Urol 2006;176(2):600-3.

Saigal CS, Joyce G, Timilsina AR; Urologic diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 2005;68:1808-14.

Heilberg IP, Weisinger JR. Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 2006;15(4):394-402.

Pak CY, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, et al. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 1980;69:19-30.

Park C, Ha YS, Kim YJ, Yun SJ, Lee SC, Kim WJ. Comparison of metabolic risk factors in urolithiasis patients according to family history. Korean J Urol 2010;51:50-3.

Mustafa Kıraç, Bora Küpeli, Lokman İrkilata, Özlem Gülbahar, Nur Aksakal, Üstünol Karaoğlan, et al. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones. Kaohsiung J Med Sci 2013;29(2):88-92.

Mandel N. Mechanism of stone formation. Semin Nephrol 1996;16:364-74.

Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. Engl J Med 1979;300:337-40.

Kwon OJ, Ahn SH. Comparison of the lithogenic risk factors for first time and recurrent stone-formers. Korean J Urol 2006;47:1093-8.

Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997;8:1568-73.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Muhammad Naeem, Tariq Ahmad, Muhammad Kamran Khan, Hazrat Ullah

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.